Ian Mortimer Insider Trading Activity
Ian Mortimer has been net-selling over the last 12 months with 0 purchases and 18 sales across 1 company.
XENE is the most-traded position with 18 trades. The largest single transaction was a sale of XENE for $4.0M on Mar 9, 2026.
Performance Scorecard
Forward stock performance after each transaction by Ian Mortimer. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +4.0% | 89% | 18 |
| 90 days | — | -0.1% | 72% | 18 |
| 120 days | — | -13.8% | 0% | 18 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersXENE · Xenon Pharmaceuticals Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Ian Mortimer bought and sold XENE.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Mar 13, 2026 | XENE | Sell | 7,308 | $55.23 | $404K | −26.8% | CEO | |
Mar 10, 2026 | XENE | Sell | 11,269 | $60.11 | $677K | −43.3% | CEO | |
Mar 9, 2026 | XENE | Sell | 31,694 | $59.88 | $1.9M | −53.5% | CEO | |
Mar 9, 2026 | XENE | Sell | 21,515 | $60.49 | $1.3M | −78.2% | CEO | |
Mar 9, 2026 | XENE | Sell | 12,479 | $59.50 | $743K | −40.3% | CEO | |
Mar 9, 2026 | XENE | Sell | 10,072 | $60.47 | $609K | −54.4% | CEO | |
Mar 9, 2026 | XENE | Sell | 2,449 | $61.26 | $150K | −29.0% | CEO | |
Mar 9, 2026 | XENE | Sell | 43,348 | $59.26 | $2.6M | −37.4% | CEO | |
Mar 9, 2026 | XENE | Sell | 61,652 | $60.08 | $3.7M | −91.1% | CEO | |
Mar 9, 2026 | XENE | Sell | 65,000 | $62.06 | $4.0M | −91.5% | CEO | |
Mar 9, 2026 | XENE | Sell | 21,791 | $58.81 | $1.3M | −26.9% | CEO | |
Jan 2, 2026 | XENE | Sell | 37,938 | $44.40 | $1.7M | −82.5% | CEO | |
Jan 2, 2026 | XENE | Sell | 2,062 | $44.93 | $93K | −25.6% | CEO | |
Dec 8, 2025 | XENE | Sell | 8,820 | $45.59 | $402K | −52.4% | CEO | |
Dec 8, 2025 | XENE | Sell | 2,010 | $46.32 | $93K | −25.1% | CEO | |
Dec 5, 2025 | XENE | Sell | 14,375 | $45.03 | $647K | −46.1% | CEO | |
Nov 28, 2025 Filed 3d late | XENE | Sell | 97 | $45.01 | $4K | −0.3% | CEO | |
Oct 1, 2025 | XENE | Sell | 25,000 | $40.16 | $1.0M | −44.4% | CEO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc. | 18 | $21.3M |